Rigel Pharmaceuticals
RIGL
RIGL
135 hedge funds and large institutions have $503M invested in Rigel Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.25% less ownership
Funds ownership: 9.65% → 9.41% (-0.25%)
45% less call options, than puts
Call options by funds: $788K | Put options by funds: $1.43M
Holders
135
Holding in Top 10
1
Calls
$788K
Puts
$1.43M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$6.18M | |
| 3 | +$4.05M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.23M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$3.17M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$9.64M | |
| 3 | -$4.24M | |
| 4 |
JP Morgan Chase
New York
|
-$4.09M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.95M |